CRAMSN

CRAMSN provides integrated CRO, CDMO, and CMO services spanning drug substance and drug product development and manufacturing. The organization operates state-of-the-art R&D centers and multiple manufacturing facilities, including dedicated drug substance/finished dosage form (DS/FDF) facilities and an FDF manufacturing facility in New Jersey, USA.

Core Capabilities:

• Drug substance development and manufacturing
• Drug product (finished dosage form) development and manufacturing
• Process engineering including process safety studies (RC1, DSC, TSU), process simulation, equipment selection, and scale-up support
• Quality management including document compilation, method transfer, validation, and raw material/intermediate analysis
• Environment, health & safety services including process hazard assessment (PHA), HAZOP studies, and green chemistry promotion
• Supply chain management and strategic sourcing
• Project management with dedicated single point of contact

Regulatory & Sustainability: Facilities are certified and recognized by US FDA, EU, Japan, Canada, and other regulatory authorities. The organization emphasizes sustainable practices including green chemistry, solar-powered facilities, and net-zero waste objectives.